Read the full stored bill text
House
File
852
-
Introduced
HOUSE
FILE
852
BY
COMMITTEE
ON
COMMERCE
(SUCCESSOR
TO
HSB
99)
A
BILL
FOR
An
Act
relating
to
pharmacy
benefits
managers,
pharmacies,
and
1
prescription
drugs
and
including
applicability
provisions.
2
BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
3
TLSB
1492HV
(1)
91
nls/ko
H.F.
852
Section
1.
Section
510B.1,
Code
2025,
is
amended
by
adding
1
the
following
new
subsections:
2
NEW
SUBSECTION
.
11A.
“Pass-through
pricing”
means
a
3
model
of
prescription
drug
pricing
in
which
payments
made
4
by
a
third-party
payor
to
a
pharmacy
benefits
manager
for
5
prescription
drugs
are
equivalent
to
the
payments
the
pharmacy
6
benefits
manager
makes
to
the
dispensing
pharmacy
or
dispensing
7
health
care
provider
for
the
prescription
drugs,
including
any
8
professional
dispensing
fee.
9
NEW
SUBSECTION
.
21A.
“Spread
pricing”
means
a
pharmacy
10
benefits
manager
charges
a
third-party
payor
more
for
11
prescription
drugs
dispensed
to
a
covered
person
than
the
12
amount
the
pharmacy
benefits
manager
reimburses
the
pharmacy
13
for
dispensing
the
prescription
drugs
to
a
covered
person.
14
Sec.
2.
Section
510B.4,
Code
2025,
is
amended
by
adding
the
15
following
new
subsection:
16
NEW
SUBSECTION
.
4.
A
pharmacy
benefits
manager,
health
17
carrier,
health
benefit
plan,
or
third-party
payor
shall
not
18
discriminate
against
a
pharmacy
or
a
pharmacist
with
respect
to
19
participation,
referral,
reimbursement
of
a
covered
service,
20
or
indemnification
if
a
pharmacist
is
acting
within
the
scope
21
of
the
pharmacist’s
license
and
the
pharmacy
is
operating
in
22
compliance
with
all
applicable
laws
and
rules.
23
Sec.
3.
NEW
SECTION
.
510B.4B
Prohibited
conduct
——
pharmacy
24
rights.
25
1.
A
pharmacy
benefits
manager
shall
not
do
any
of
the
26
following:
27
a.
Where
a
pharmacy
or
pharmacist
has
agreed
to
participate
28
in
a
covered
person’s
health
benefit
plan,
prohibit
or
limit
29
the
covered
person
from
selecting
a
pharmacy
or
pharmacist
of
30
the
covered
person’s
choice,
or
impose
a
monetary
advantage
31
or
penalty
that
would
affect
a
covered
person’s
choice.
A
32
monetary
advantage
or
penalty
includes
a
higher
copayment,
a
33
reduction
in
reimbursement
for
services,
or
promotion
of
one
34
participating
pharmacy
over
another.
35
-1-
LSB
1492HV
(1)
91
nls/ko
1/
10
H.F.
852
b.
Deny
a
pharmacy
or
pharmacist
the
right
to
participate
as
1
a
contract
provider
under
a
health
benefit
plan
if
the
pharmacy
2
or
pharmacist
agrees
to
provide
pharmacy
services
that
meet
3
the
terms
and
requirements
of
the
health
benefit
plan
and
the
4
pharmacy
or
pharmacist
agrees
to
the
terms
of
reimbursement
set
5
forth
by
the
third-party
payor.
6
c.
Impose
upon
a
pharmacy
or
pharmacist,
as
a
condition
7
of
participation
in
a
third-party
payor
network,
any
course
8
of
study,
accreditation,
certification,
or
credentialing
that
9
is
inconsistent
with,
more
stringent
than,
or
in
addition
to
10
state
requirements
for
licensure
or
certification,
and
the
11
administrative
rules
adopted
by
the
board
of
pharmacy.
12
d.
Unreasonably
designate
a
prescription
drug
as
a
13
specialty
drug
to
prevent
a
covered
person
from
accessing
14
the
prescription
drug,
or
limiting
a
covered
person’s
access
15
to
the
prescription
drug,
from
a
pharmacy
or
pharmacist
that
16
is
within
the
health
carrier’s
network.
A
covered
person
or
17
pharmacy
harmed
by
an
alleged
violation
of
this
paragraph
may
18
file
a
complaint
with
the
commissioner,
and
the
commissioner
19
shall,
in
consultation
with
the
board
of
pharmacy,
make
a
20
determination
as
to
whether
the
covered
prescription
drug
meets
21
the
definition
of
a
specialty
drug.
22
e.
Require
a
covered
person,
as
a
condition
of
payment
23
or
reimbursement,
to
purchase
pharmacy
services,
including
24
prescription
drugs,
exclusively
through
a
mail
order
pharmacy.
25
f.
Impose
upon
a
covered
person
a
copayment,
reimbursement
26
amount,
number
of
days
of
a
prescription
drug
supply
for
27
which
reimbursement
will
be
allowed,
or
any
other
payment
28
or
condition
relating
to
purchasing
pharmacy
services
from
29
a
pharmacy
that
is
more
costly
or
restrictive
than
would
be
30
imposed
upon
the
covered
person
if
such
pharmacy
services
were
31
purchased
from
a
mail
order
pharmacy,
or
any
other
pharmacy
32
that
can
provide
the
same
pharmacy
services
for
the
same
cost
33
and
copayment
as
a
mail
order
service.
34
2.
a.
If
a
third-party
payor
providing
reimbursement
to
35
-2-
LSB
1492HV
(1)
91
nls/ko
2/
10
H.F.
852
covered
persons
for
prescription
drugs
restricts
pharmacy
1
participation,
the
third-party
payor
shall
notify,
in
writing,
2
all
pharmacies
within
the
geographical
coverage
area
of
the
3
health
benefit
plan
restriction,
and
offer
the
pharmacies
4
the
opportunity
to
participate
in
the
health
benefit
plan
at
5
least
sixty
days
prior
to
the
effective
date
of
the
health
6
benefit
plan
restriction.
All
pharmacies
in
the
geographical
7
coverage
area
of
the
health
benefit
plan
shall
be
eligible
to
8
participate
under
identical
reimbursement
terms
for
providing
9
pharmacy
services
and
prescription
drugs.
10
b.
The
third-party
payor
shall
inform
covered
persons
of
11
the
names
and
locations
of
all
pharmacies
participating
in
12
the
health
benefit
plan
as
providers
of
pharmacy
services
and
13
prescription
drugs.
14
c.
A
participating
pharmacy
shall
be
entitled
to
announce
15
the
pharmacy’s
participation
in
the
health
benefit
plan
to
the
16
pharmacy’s
customers.
17
3.
The
commissioner
shall
not
certify
a
pharmacy
benefits
18
manager
or
license
an
insurance
producer
that
is
not
in
19
compliance
with
this
section.
20
4.
A
covered
person
or
pharmacy
injured
by
a
violation
21
of
this
section
may
maintain
a
cause
of
action
to
enjoin
the
22
continuation
of
the
violation.
23
5.
This
section
shall
not
apply
to
an
entity
that
owns
24
and
operates
the
entity’s
own
facility,
employs
or
contracts
25
with
physicians,
pharmacists,
nurses,
or
other
health
care
26
personnel,
and
that
dispenses
prescription
drugs
from
the
27
entity’s
pharmacy
to
the
entity’s
employees
and
dependents
28
enrolled
in
the
entity’s
health
benefit
plan,
except
that
29
this
section
shall
apply
to
an
entity
otherwise
excluded
that
30
contracts
with
an
outside
pharmacy
or
group
of
pharmacies
31
to
provide
prescription
drugs
and
services
to
the
entity’s
32
employees
and
dependents
enrolled
in
the
entity’s
health
33
benefit
plan.
34
Sec.
4.
Section
510B.8,
Code
2025,
is
amended
by
adding
the
35
-3-
LSB
1492HV
(1)
91
nls/ko
3/
10
H.F.
852
following
new
subsections:
1
NEW
SUBSECTION
.
3.
A
pharmacy
benefits
manager
shall
not
2
impose
different
cost-sharing
or
additional
fees
on
a
covered
3
person
based
on
the
pharmacy
at
which
the
covered
person
fills
4
a
prescription
drug
order.
5
NEW
SUBSECTION
.
4.
a.
A
covered
person’s
cost-sharing
6
for
a
prescription
drug
shall
be
calculated
at
the
point
of
7
sale
based
on
a
price
that
is
reduced
by
an
amount
equal
to
8
at
least
one
hundred
percent
of
all
rebates
that
have
been
9
received,
or
that
will
be
received,
by
the
health
carrier
or
a
10
pharmacy
benefits
manager
in
connection
with
the
dispensing
or
11
administration
of
the
prescription
drug.
12
b.
A
health
carrier
shall
not
be
precluded
from
decreasing
13
a
covered
person’s
cost-sharing
by
an
amount
greater
than
the
14
covered
person’s
cost-sharing
as
calculated
under
paragraph
15
“a”
.
16
NEW
SUBSECTION
.
5.
A
pharmacy
benefits
manager
shall
17
include
any
amount
paid
by
a
covered
person,
or
on
behalf
of
18
a
covered
person,
when
calculating
the
covered
person’s
total
19
contribution
toward
the
covered
person’s
cost-sharing.
20
NEW
SUBSECTION
.
6.
Any
amount
paid
by
a
covered
person
for
21
a
prescription
drug
shall
be
applied
to
any
deductible
imposed
22
on
the
covered
person
by
the
covered
person’s
health
benefit
23
plan
in
accordance
with
the
health
benefit
plan’s
coverage
24
documents.
25
Sec.
5.
Section
510B.8B,
Code
2025,
is
amended
to
read
as
26
follows:
27
510B.8B
Pharmacy
benefits
manager
affiliates
managers
——
28
reimbursement
reimbursements
.
29
1.
A
pharmacy
benefits
manager
shall
not
reimburse
any
30
pharmacy
located
in
the
state
in
an
amount
less
than
the
amount
31
that
the
pharmacy
benefits
manager
reimburses
a
pharmacy
32
benefits
manager
affiliate
for
dispensing
the
same
prescription
33
drug
as
dispensed
by
the
pharmacy.
The
reimbursement
amount
34
shall
be
calculated
on
a
per
unit
basis
based
on
the
same
35
-4-
LSB
1492HV
(1)
91
nls/ko
4/
10
H.F.
852
generic
product
identifier
or
generic
code
number.
1
2.
A
pharmacy
benefits
manager
shall
not
reimburse
any
2
pharmacy
located
in
the
state
in
an
amount
less
than
the
most
3
recently
published
national
average
drug
acquisition
cost
or
4
the
Iowa
average
acquisition
cost
for
the
prescription
drug
5
on
the
date
that
the
prescription
drug
is
administered
or
6
dispensed.
If
the
most
recently
published
national
average
7
drug
acquisition
cost
and
the
Iowa
average
acquisition
cost
8
for
the
prescription
drug
are
unavailable
on
the
date
that
the
9
prescription
drug
is
administered
or
dispensed,
a
pharmacy
10
benefits
manager
shall
not
reimburse
any
pharmacy
located
in
11
the
state
in
an
amount
less
than
the
wholesale
acquisition
cost
12
for
the
prescription
drug
on
the
date
that
the
prescription
13
drug
is
administered
or
dispensed.
14
3.
In
addition
to
the
reimbursement
required
under
15
subsection
2,
a
pharmacy
benefits
manager
shall
reimburse
the
16
pharmacy
or
pharmacist
a
professional
dispensing
fee
in
an
17
amount
not
less
than
the
pharmacy
dispensing
fee
published
in
18
the
Iowa
Medicaid
enterprise
provider
fee
schedule
on
the
date
19
that
the
prescription
drug
is
administered
or
dispensed.
20
4.
A
pharmacy
may
decline
to
dispense
a
prescription
drug
21
to
a
covered
person
if
the
requirements
of
subsections
2
and
3
22
cannot
be
met.
23
Sec.
6.
NEW
SECTION
.
510B.8D
Pharmacy
benefits
manager
24
contracts
——
spread
pricing.
25
1.
All
contracts
executed,
amended,
adjusted,
or
renewed
26
on
or
after
July
1,
2025,
that
apply
to
prescription
drug
27
benefits
on
or
after
January
1,
2026,
between
a
pharmacy
28
benefits
manager
and
a
third-party
payor,
or
between
a
person
29
and
a
third-party
payor,
shall
include
all
of
the
following
30
requirements:
31
a.
The
pharmacy
benefits
manager
shall
use
pass-through
32
pricing
unless
paragraph
“b”
applies.
33
b.
The
pharmacy
benefits
manager
may
use
direct
or
indirect
34
spread
pricing
only
if
the
difference
between
the
amount
the
35
-5-
LSB
1492HV
(1)
91
nls/ko
5/
10
H.F.
852
third-party
payor
pays
the
pharmacy
benefits
manager
for
a
1
prescription
drug
and
the
amount
the
pharmacy
benefits
manager
2
reimburses
the
dispensing
pharmacy
or
dispensing
health
care
3
provider
for
the
prescription
drug
is
passed
through
by
the
4
pharmacy
benefits
manager
to
the
person
contracted
to
receive
5
third-party
payor
services.
6
c.
Payments
received
by
a
pharmacy
benefits
manager
for
7
services
provided
by
the
pharmacy
benefits
manager
to
a
8
third-party
payor
or
to
a
pharmacy
shall
be
used
or
distributed
9
pursuant
to
the
pharmacy
benefits
manager’s
contract
with
10
the
third-party
payor
or
with
the
pharmacy,
or
as
otherwise
11
required
by
law.
12
2.
Unless
otherwise
prohibited
by
law,
subsection
1
shall
13
supersede
any
contractual
terms
to
the
contrary
in
any
contract
14
executed,
amended,
adjusted,
or
renewed
on
or
after
July
1,
15
2025,
that
applies
to
prescription
drug
benefits
on
or
after
16
January
1,
2026,
between
a
pharmacy
benefits
manager
and
a
17
third-party
payor,
or
between
a
person
and
a
third-party
payor.
18
Sec.
7.
NEW
SECTION
.
510B.8E
Appeals
and
disputes.
19
1.
A
pharmacy
benefits
manager
shall
provide
a
reasonable
20
process
to
allow
a
pharmacy
to
appeal
a
reimbursement
rate
for
21
a
specific
prescription
drug
for
any
of
the
following
reasons:
22
a.
The
pharmacy
benefits
manager
violated
section
510B.8A.
23
b.
The
reimbursement
rate
is
below
the
pharmacy
acquisition
24
cost.
25
2.
The
appeals
process
must
include
all
of
the
following:
26
a.
A
dedicated
telephone
number
at
which
a
pharmacy
may
27
contact
the
pharmacy
benefits
manager
and
speak
directly
with
28
an
individual
who
is
involved
with
the
appeals
process.
29
b.
A
dedicated
electronic
mail
address
or
internet
site
for
30
the
purpose
of
submitting
an
appeal
directly
to
the
pharmacy
31
benefits
manager.
32
c.
A
period
of
no
less
than
thirty
business
days
after
the
33
date
of
a
pharmacy’s
initial
submission
of
a
clean
claim
during
34
which
the
pharmacy
may
initiate
an
appeal.
35
-6-
LSB
1492HV
(1)
91
nls/ko
6/
10
H.F.
852
3.
The
pharmacy
benefits
manger
shall
respond
to
an
appeal
1
within
seven
business
days
after
the
date
on
which
the
pharmacy
2
benefits
manager
receives
the
appeal.
3
a.
If
the
pharmacy
benefits
manager
grants
a
pharmacy’s
4
appeal,
the
pharmacy
benefits
manager
shall
do
all
of
the
5
following:
6
(1)
Adjust
the
reimbursement
rate
of
the
prescription
drug
7
that
is
the
subject
of
the
appeal
and
provide
the
national
drug
8
code
number
that
the
adjustment
is
based
on
to
the
appealing
9
pharmacy.
10
(2)
Reverse
and
resubmit
the
claim
that
is
the
subject
of
11
the
appeal.
12
(3)
Make
the
adjustment
pursuant
to
subparagraph
(1)
13
applicable
to
all
of
the
following:
14
(a)
Each
pharmacy
that
is
under
common
ownership
with
the
15
pharmacy
that
submitted
the
appeal.
16
(b)
Each
pharmacy
in
the
state
that
demonstrates
the
17
inability
to
purchase
the
prescription
drug
for
less
than
the
18
established
reimbursement
rate.
19
b.
If
the
pharmacy
benefits
manager
denies
a
pharmacy’s
20
appeal,
the
pharmacy
benefits
manager
shall
do
all
of
the
21
following:
22
(1)
Provide
the
appealing
pharmacy
the
national
drug
23
code
number
and
the
name
of
a
wholesale
distributor
licensed
24
pursuant
to
section
155A.17
from
which
the
pharmacy
can
obtain
25
the
prescription
drug
at
or
below
the
reimbursement
rate.
26
(2)
If
the
prescription
drug
identified
by
the
national
27
drug
code
number
provided
by
the
pharmacy
benefits
manager
28
pursuant
to
subparagraph
(1)
is
not
available
below
the
29
pharmacy
acquisition
cost
from
the
wholesale
distributor
from
30
whom
the
pharmacy
purchases
the
majority
of
its
prescription
31
drugs
for
resale,
the
pharmacy
benefits
manager
shall
adjust
32
the
reimbursement
rate
above
the
appealing
pharmacy’s
pharmacy
33
acquisition
cost,
and
reverse
and
resubmit
each
claim
affected
34
by
the
pharmacy’s
inability
to
procure
the
prescription
drug
35
-7-
LSB
1492HV
(1)
91
nls/ko
7/
10
H.F.
852
at
a
cost
that
is
equal
to
or
less
than
the
previously
appealed
1
reimbursement
rate.
2
Sec.
8.
APPLICABILITY.
This
Act
applies
to
pharmacy
3
benefits
managers
that
manage
a
prescription
drug
benefit
in
4
the
state
on
or
after
July
1,
2025.
5
EXPLANATION
6
The
inclusion
of
this
explanation
does
not
constitute
agreement
with
7
the
explanation’s
substance
by
the
members
of
the
general
assembly.
8
This
bill
relates
to
pharmacy
benefits
managers
(PBMs),
9
pharmacies,
and
prescription
drugs.
10
The
bill
prohibits
a
PBM
from
discriminating
against
11
a
pharmacy
or
a
pharmacist
with
regards
to
participation,
12
referral,
reimbursement
of
a
covered
service,
or
13
indemnification
if
a
pharmacist
acts
within
the
scope
of
14
the
pharmacist’s
license
and
the
pharmacy
is
operating
in
15
accordance
with
all
applicable
laws
and
rules.
16
Under
the
bill,
where
a
pharmacy
or
pharmacist
has
agreed
17
to
participate
in
a
covered
person’s
(person’s)
health
benefit
18
plan
(plan),
a
PBM
shall
not
prohibit
or
limit
the
person
from
19
selecting
a
pharmacy
or
pharmacist
of
their
choice,
or
impose
20
a
monetary
advantage
or
penalty
as
described
in
the
bill.
21
A
PBM
shall
not
deny
a
pharmacy
or
pharmacist
the
right
to
22
participate
as
a
contract
provider
under
a
plan
if
the
pharmacy
23
or
pharmacist
agrees
to
the
terms
and
requirements
of
the
plan
24
and
the
terms
of
reimbursement.
A
PBM
shall
not
impose
upon
25
a
pharmacy
or
pharmacist,
as
a
condition
of
participation
in
26
a
network,
any
course
of
study,
accreditation,
certification,
27
or
credentialing
different
than
state
requirements
and
rules
28
of
the
board
of
pharmacy.
A
PBM
shall
not
unreasonably
29
designate
a
prescription
drug
(prescription)
as
a
specialty
30
drug
to
prevent
a
person
from
accessing
the
prescription
or
to
31
limit
a
person’s
access
to
the
prescription
from
a
pharmacy
32
or
pharmacist
that
is
within
the
person’s
plan’s
network.
33
A
person
or
pharmacy
harmed
by
such
a
violation
may
file
a
34
complaint.
A
PBM
shall
not
require
a
person,
as
a
condition
35
-8-
LSB
1492HV
(1)
91
nls/ko
8/
10
H.F.
852
of
payment
or
reimbursement,
to
purchase
pharmacy
services
1
exclusively
through
a
mail
order
pharmacy.
A
PBM
shall
not
2
impose
upon
a
person
any
payment
or
condition
to
purchasing
3
pharmacy
services
that
is
more
costly
or
restrictive
than
if
4
such
services
were
purchased
from
a
mail
order
pharmacy,
or
any
5
other
pharmacy.
6
If
a
third-party
payor
providing
reimbursement
to
persons
7
for
prescriptions
restricts
pharmacy
participation,
the
8
third-party
payor
shall
notify,
in
writing,
all
pharmacies
9
within
the
geographical
coverage
area
of
the
plan,
and
offer
10
the
opportunity
to
participate
in
the
plan
at
least
60
days
11
prior
to
the
effective
date
of
the
restriction.
All
pharmacies
12
in
the
geographical
coverage
area
are
eligible
to
participate
13
under
identical
reimbursement
terms.
The
third-party
payor
14
shall
inform
persons
of
the
names
and
locations
of
all
15
pharmacies
participating
in
the
plan.
A
participating
pharmacy
16
shall
be
entitled
to
announce
the
pharmacy’s
participation
to
17
the
pharmacy’s
customers.
The
commissioner
shall
not
certify
18
any
PBM
or
license
an
insurance
producer
not
in
compliance
with
19
the
bill.
20
A
PBM
shall
not
impose
different
cost-sharing
or
additional
21
fees
on
a
person
based
on
the
pharmacy
at
which
the
person
22
fills
a
prescription
order.
A
person’s
cost-sharing
for
a
23
prescription
shall
be
calculated
at
the
point
of
sale
based
24
on
a
price
that
is
reduced
by
an
amount
equal
to
at
least
100
25
percent
of
all
rebates
that
have
been
received,
or
will
be
26
received,
by
the
health
carrier
or
a
PBM
in
connection
with
27
the
dispensing
or
administration
of
the
prescription.
A
PBM
28
shall
include
any
amount
paid
by
a
person,
or
on
behalf
of
a
29
person,
when
calculating
the
person’s
total
contribution
toward
30
the
person’s
cost-sharing.
Any
amount
paid
by
a
person
for
a
31
prescription
shall
be
applied
to
any
deductible
imposed
on
the
32
person
by
the
person’s
plan
in
accordance
with
the
coverage
33
documents.
34
The
bill
prohibits
a
PBM
from
reimbursing
a
pharmacy
in
an
35
-9-
LSB
1492HV
(1)
91
nls/ko
9/
10
H.F.
852
amount
less
than
the
national
average
drug
acquisition
cost
or
1
the
Iowa
average
acquisition
cost
or,
if
neither
is
available,
2
the
wholesale
acquisition
cost,
for
a
prescription
on
the
date
3
that
the
prescription
is
administered
or
dispensed.
A
PBM
4
also
must
reimburse
the
pharmacy
or
pharmacist
a
professional
5
dispensing
fee
in
an
amount
not
less
than
the
pharmacy
6
dispensing
fee
published
in
the
Iowa
Medicaid
enterprise
7
provider
fee
schedule
on
the
date
that
the
prescription
8
is
administered
or
dispensed.
The
bill
permits
a
pharmacy
9
to
decline
to
dispense
a
prescription
to
a
person
if
the
10
pharmacy
will
be
reimbursed
less
for
the
prescription
than
the
11
pharmacy’s
acquisition
cost.
12
The
bill
requires
all
contracts
executed,
amended,
adjusted,
13
or
renewed
on
or
after
July
1,
2025,
that
are
applicable
14
to
prescription
drug
benefits
on
or
after
January
1,
2026,
15
between
a
PBM
and
a
third-party
payor,
or
between
a
person
16
and
a
third-party
payor,
to
use
a
pass-through
pricing
model;
17
to
exclude
terms
that
allow
for
spread
pricing
unless
the
18
entire
amount
of
the
difference
caused
by
spread
pricing
is
19
passed
through
by
the
PBM;
and
to
ensure
that
payments
received
20
in
relation
to
providing
services
to
a
third-party
payor
or
21
a
pharmacy
are
used
or
distributed
pursuant
to
the
PBM’s
22
contract
with
the
third-party
payor
or
with
the
pharmacy,
or
23
as
otherwise
required.
“Pass-through
pricing”
and
“spread
24
pricing”
are
defined
in
the
bill.
25
The
bill
requires
a
PBM
to
provide
a
process
for
pharmacies
26
to
appeal
a
reimbursement
rate
for
a
specific
prescription.
27
The
appeal
process
is
detailed
in
the
bill.
28
The
bill
applies
to
pharmacy
benefits
managers
that
manage
29
a
prescription
drug
benefit
in
the
state
on
or
after
July
1,
30
2025.
31
-10-
LSB
1492HV
(1)
91
nls/ko
10/
10